Document is current
Any future updates will be listed below
-
Authors
Mun, Chung Jung
Reid, Matthew J.
Sarandos, Sarah
Elam, Kit K.
Li, Celine Mylx
Strickland, Justin C.
-
Funding
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (R01NS129887)
National Institute on Drug Abuse (R01DA055634)
- License Information
-
More Information
Article History
Accepted: 21 August 2024
First Online: 11 September 2024
Declarations
:
: Not applicable.
: MJR has received research funding and other financial and non-financial support from The Sackler Foundation (Purdue Pharma) for work unrelated to opioids or substance use disorders. JCS has received research related funding from Canopy Growth Corporation and DynamiCare Health and consulting fees from Merck Corporation in the past three years for work unrelated to the orexin system. The remaining authors declare that they have no conflicts of interest.
